Clinical Trials Directory

Trials / Completed

CompletedNCT02776514

Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis

Intraarticular Injections of Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Balgrist University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study investigates clinical outcome and imaging outcome parameters after intraarticular injection of steroids, platelet-rich-plasma (prp), hyaluronic acid or placebo in patients with early osteoarthritis of the knee joint.

Detailed description

Osteoarthritis of the knee joint is a very common disease in middle aged and elderly patients. This study evaluates the efficiency of different commonly used substances for intraarticular, non-operative treatment in early stages of this disease. 120 patients receive an fluoroscopic guided injection in the knee joint: 30 patients get injection with steroids 30 patients get injection with prp 30 patients get injection with hyaluronic acid 30 patients get injection with placebo (iopamiro contrast media) Primary outcome: - clinical outcome (pain using numeric rating scale) * Magnetic Resonance imaging (cartilage defects etc.)

Conditions

Interventions

TypeNameDescription
DRUGTriamcortFluoroscopic guided injection in the knee joint
DRUGPlatelet-rich-plasma
DRUGSuplasyn1
DRUGPlacebo

Timeline

Start date
2016-02-01
Primary completion
2020-11-01
Completion
2020-11-01
First posted
2016-05-18
Last updated
2022-02-07

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02776514. Inclusion in this directory is not an endorsement.